DVA DaVita Inc.

156.34USD-3.37%Mkt Cap: 9.83B USDP/E: 11.83

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap9.83B USD
Enterprise Value24.72B USD
Revenue (TTM)14.17B USD
Gross Profit4.40B USD
Net Income (TTM)746.80M USD
Revenue/Share213.39 USD
Last Price156.34 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees78.0K
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)11.83
P/E (Forward)9.24
PEG0.40
EV/EBITDA8.68
EV/Revenue1.74
P/S0.69
P/B-16.77
EPS (TTM)13.21 USD
EPS (Forward)16.88 USD
52W Range
101.0038% of range247.49
52W High247.49 USD
52W Low101.00 USD
Profitability
Gross Margin32.25%
Oper. Margin15.17%
EBITDA Margin20.09%
Profit Margin5.47%
ROE-114.70%
ROA4.27%
ROIC11.80%
ROCE14.02%
Growth
Revenue Growth4.60%
Earnings Growth66.70%
Cash Flow & Leverage
Operating CF1.89B USD
CapEx (TTM)575.86M USD
FCF Margin6.39%
FCF Yield9.20%
Net Debt12.83B USD
Net Debt/EBITDA4.51
Net Debt/FCF14.17
Balance Sheet
Debt/Equity-19.77
Current Ratio1.41
Quick Ratio1.28
Book Value/Sh-9.32 USD
Cash/Share9.00 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateSep 9, 2013
Analyst Consensus
Rating2.5 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)222.29 USD
Upside (mean)+42.2%
Target Range165.00 USD – 287.00 USD
165.00+42.2% to mean287.00
# Analysts7
Ownership
Shares Out.62.90M
Float33.44M
Insiders46.97%
Institutions51.43%
Short Interest
Short Ratio6.9d
Short % Float16.30%
Short % Out.8.17%
Shares Short5.14M
Short (prev mo.)5.15M
Technical
SMA 50182.46 (-14.3%)
SMA 200181.24 (-13.7%)
Beta0.86
S&P 52W Chg12.08%
Avg Vol (30d)803.84K
Avg Vol (10d)747.64K
Technical Indicators
RSI (14)30.2
MACD-4.7418
MACD Signal-1.6480
MACD Hist.-3.0938
BB Upper201.07 USD
BB Middle181.16 USD
BB Lower161.25 USD
BB Width21.98%
ATR (14)7.185 USD
Vol Ratio (20d)1.45x

About DaVita (NYSE: DVA)

›

DaVita (NYSE: DVA) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 78,000 employees.

The shares were at 156.34 USD on 19 November 2026, up 28.6% over 52 weeks. Its 52-week range is 101.00 USD to 247.49 USD: the price is 36.8% below the high and 54.8% above the low.

At a market capitalisation of 9.83B USD, it trades at 11.8 times trailing earnings and 9.2 times forward earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 23.7, a discount of 50% for DVA.

DaVita reports return on equity of -114.7%, an operating margin of 15.2% and revenue up 4.6% year over year.

Its debt exceeds its cash by 12.83B USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 7 analysts cover the stock, with an average rating of Hold; their mean price target of 222.29 USD is 42.2% above the current price. The next earnings report is expected on 1 February 2027.